News
Robotic surgery devices market to reach $10 billion in 2024
As the healthcare landscape continues to evolve with technological advancements, the field of robotic surgery and devices is expected to experience unprecedented growth in 2024. The expansion will be driven by a surge in demand for minimally invasive procedures and advancements in robotic technologies. The global market for robotic surgical systems and accessories is projected to hit $10 billion by the end of 2024, with an anticipated surge to $15.8 billion by 2030, according to GlobalData. Various factors contribute to the growth of
robotic surgery, including rising demand from the expanding elderly demographic seeking minimally invasive and precise surgical solutions, the focus on value-based healthcare to improve surgical results, and continuous technological progress fostering the creation of more effective and less invasive robotic surgical platforms. Graysen Vigneux, Medical Analyst at GlobalData, commented: “Innovation in robotic surgery is propelling us towards a future where surgeries once deemed too risky or intricate become routine, all thanks to the precision and versatility of these cutting-edge devices. The market’s surge in 2024 signals a new chapter in healthcare, where precision, efficiency, and patient-focused approaches are reshaping the landscape.” Additionally, technological advancements such
as artificial intelligence (AI) and machine learning algorithms are further advancing the evolution of robotic surgery and devices. These innovations empower surgeons with real-time data analytics,
Sponsored by
NHS roll out of sponge-on-a-string test for screening
predictive modelling, and personalised treatment recommendations, thereby revolutionising the way surgeries are performed and patients are cared for. Moreover, it is evident that the rising demand for minimally invasive surgeries and ongoing technological advancements are driving sustained growth in the robotic surgery and devices market. Stakeholders from the healthcare, tech, and investment sectors are actively pouring resources into innovative solutions, marking a pivotal shift in surgical practices and patient care. Vigneux concluded: “The advancements in
robotic surgery devices signal a paradigm shift in how we approach surgical interventions. With each innovation, we inch closer to a future where surgery is not just about healing but about enhancing quality of life.”
An innovative test trialled by the NHS to help diagnose Barrett’s oesophagus, which can lead to oesophageal cancer, has reduced the need for invasive endoscopy in thousands of low-risk patients. The NHS pilot has tested over 8,500 patients with the capsule sponge test. Evaluation of a cohort of patients showed almost eight out of 10 patients, who completed a test were discharged without the need for further testing, freeing up endoscopy capacity for higher risk patients and those referred for urgent tests for oesophageal cancer. The test involves patients swallowing a small capsule-shaped device which contains a tiny sponge that collects cell samples for analysis before being extracted via a string attached to the sponge. Amanda Pritchard, NHS chief executive, said:
“Thousands of people have now benefitted from this incredibly efficient test on the NHS – while the sponge on a string is small in size, it can make a big difference for patients – they can conveniently fit the test into their day and it can often replace the need for an endoscopy while also helping to reduce waiting lists by freeing up staff and
resources...This simple sponge on a string test is just one example of many pioneering tools we’ve trialled in recent years to help diagnose and treat people sooner.”
Around one million UK adults are unaware they have diabetes
A new analysis has revealed that approximately 30% of people living with type 2 diabetes in England, or around one million adults, are undiagnosed, while around one in nine of all adults in England are estimated to be living with prediabetes. The analysis was conducted by the Office for National Statistics (ONS) and calculated from an analysis of data between 2013-2019 from the Health Survey for England. The analysis found:
l Younger adults, if they have type 2 diabetes, were more likely to be undiagnosed – 50% of those aged 16-44 with type 2 diabetes were undiagnosed, compared to 27% of those aged 75 and over.
l People living with undiagnosed type 2 diabetes were more likely to report better general health than those with a diagnosis.
12
www.clinicalservicesjournal.com I April 2024
l Women were more likely to be undiagnosed if they had a lower body mass index (BMI), lower waist circumference, or were not prescribed antidepressants.
l Around one in nine adults were estimated to be living with prediabetes, approximately 5.1 million people in England.
l People from Black and Asian ethnic groups
had more than double the prevalence of prediabetes and undiagnosed type 2 diabetes compared to White, Mixed and Other ethnic groups.
l Those most at risk of having prediabetes were those with known risk factors for type 2 diabetes. However, significant numbers were also seen in groups typically considered low risk – for example, 8% of people not living with obesity or overweight were estimated to have prediabetes.
Nikki Joule, Policy Manager at Diabetes UK, said: “The findings are a reminder of just how important it is for type 2 diabetes to be detected and diagnosed as early as possible, so people can get treatment and support to reduce the risk of devastating complications and, importantly, be offered remission programmes where appropriate.”
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88
